REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 1st, 2020 • Heska Corp • In vitro & in vivo diagnostic substances • Delaware
This Agreement is made pursuant to that certain Series X Preferred Securities Purchase Agreement, dated as of January 12, 2020, as amended by that certain amendment dated March 30 2020, by and among the Company and the Purchasers (the “Purchase Agreement”).
ContractAmendment Agreement • April 1st, 2020 • Heska Corp • In vitro & in vivo diagnostic substances
Certain personally identifiable information contained in this document, marked by brackets as [***], has been omitted from this exhibit pursuant to Item 601(a)(6) under Regulation S-K.
AMENDMENT TO THE SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 1st, 2020 • Heska Corp • In vitro & in vivo diagnostic substances
This AMENDMENT TO THE SECURITIES PURCHASE AGREEMENT (this “Amendment”), dated as of March 30, 2020, is entered into by and among HESKA CORPORATION, a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”). Unless otherwise specifically defined herein, all capitalized terms used but not defined herein have the meaning ascribed thereto under the Securities Purchase Agreement (as defined below).
